AHRN

AHRN

Ahren Acquisition Corp.

Print
SEC filings
View on Seekingalpha
Expected Close Date
June 15, 2023
IPO Date
2021-12-15
IPO Size(M)
$ 300M
Underwriters
Citigroup

Management

Sir Shankar Balasubramanian (Principal inventor of the human genome sequencing tech core to Illumina’s platforms), Jeremy Darroch (Executive Chairman of Sky Group and Former CEO of Sky)

Management Team / Advisory Board Bios

Sir Shankar Balasubramanian (Principal inventor of the human genome sequencing tech core to Illumina’s platforms), Jeremy Darroch (Executive Chairman of Sky Group and Former CEO of Sky)
Amount Raised : $0
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment